NTSR1 and ovarian serous cystadenocarcinoma: In a cohort of 287 high-grade ovarian serous cystadenocarcinoma patients from The Cancer Genome Atlas (TCGA) database, higher expression of NTR1 mRNA was significantly associated with platinum-resistant status (p = 0.0076) [25].